T-Select H-2Ld P815 (66-74)

T-Select H-2Ld P815 (66-74) is a synthetic peptide corresponding to residues 66 through 74 of the P815 tumor antigen, presented by the murine major histocompatibility complex (MHC) class I molecule H-2Ld. As a defined peptide epitope, it plays a pivotal role in immunological research focused on antigen-specific T-cell responses, particularly within the context of mouse models. Its precise sequence and compatibility with MHC class I molecules make it an essential reagent for dissecting cellular immune mechanisms, evaluating antigen recognition, and advancing the understanding of tumor immunology.

Epitope Mapping: Researchers utilize the P815 (66-74) peptide in detailed epitope mapping studies to characterize T-cell receptor specificity and MHC-peptide interactions. By presenting this defined sequence to cytotoxic T lymphocytes (CTLs) in vitro or ex vivo, investigators can systematically examine the structural and functional requirements for antigen recognition. This approach is crucial for identifying immunodominant regions within tumor antigens and for mapping the fine specificity of T-cell responses in murine models.

Immunogenicity Assessment: The peptide is widely employed in assays designed to evaluate the immunogenic potential of tumor-associated antigens. By pulsing antigen-presenting cells with the P815 (66-74) epitope and subsequently exposing them to T-cell populations, scientists can quantify and characterize antigen-specific activation, cytokine production, and cytolytic activity. Such studies inform the selection of candidate epitopes for vaccine development and facilitate the optimization of immunotherapeutic strategies in preclinical settings.

Adoptive Cell Transfer Research: In the context of adoptive immunotherapy models, the peptide serves as a critical tool for generating and expanding antigen-specific CTLs. By stimulating T cells with the H-2Ld-restricted P815 epitope, researchers can enrich for populations with defined specificity, enabling mechanistic studies of T-cell-mediated tumor clearance. This application is instrumental in evaluating the efficacy, persistence, and functional properties of engineered or naturally occurring T cells in vivo.

Functional Assays for T-Cell Activation: Laboratories incorporate the P815 (66-74) peptide into a range of functional assays, including ELISPOT, intracellular cytokine staining, and chromium release assays, to monitor antigen-specific T-cell activation. Such assays are essential for quantifying immune responses, comparing different immunization protocols, and assessing the impact of adjuvants or immunomodulatory agents on T-cell function. The use of a well-characterized peptide epitope ensures reproducibility and specificity in these experimental systems.

Quality Control in Antigen Presentation Studies: The defined nature of the P815 (66-74) sequence makes it a reliable positive control for validating antigen processing and presentation pathways in murine models. By employing the peptide in conjunction with MHC class I-expressing cells, researchers can confirm the integrity of peptide loading, surface expression, and downstream signaling events. This application supports the development and benchmarking of new immunological assays, as well as the standardization of experimental protocols involving antigen-specific T-cell responses.

1. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs

2. A possible role of tachykinin-related peptide on an immune system activity of mealworm beetle, Tenebrio molitor L

3. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis

4. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma

5. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line